Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota.
J Am Soc Echocardiogr. 2024 Aug;37(8):752-755. doi: 10.1016/j.echo.2024.03.004. Epub 2024 Mar 16.
Mitral annulus calcification (MAC) represents a degenerative process resulting in calcium deposition in the mitral valve apparatus. Mitral annulus calcification is associated with adverse clinical outcomes. We sought to examine the long-term significance of mild MAC and its relationship to subsequent mitral valve dysfunction (MVD) and mortality in patients without MVD on the initial echocardiogram.
A total of 1,420 patients with mild MAC and no MVD at baseline and 1 or more follow-up echocardiograms at least 1 year after the baseline echocardiogram were included in the analysis. For patients with >1 echocardiogram during follow-up, the last echocardiogram was used. The same criteria were used to identify 6,496 patients without MAC. Mitral valve dysfunction was defined as mitral regurgitation (MR) and/or mitral stenosis (MS) of moderate or greater severity. Mixed disease was defined as the concurrent presence of both moderate or greater MS and MR. The primary end point was development of MVD, and the secondary end point was all-cause mortality.
For patients with mild MAC, age was 74 ± 10 years and 528 (37%) were female. Over a median follow-up of 4.7 (interquartile range, 2.7-6.9) years, 215 patients with mild MAC developed MVD, including MR in 170 (79%), MS in 37 (17%), and mixed disease in 8 (4%). In a multivariable regression model compared to patients without MAC, the presence of mild MAC was independently associated with increased mortality (hazard ratio = 1.43; 95% CI 1.24, 1.66; P < .001). Kaplan-Meier 4-year survival rates were 80% and 90% for patients with mild MAC and no MAC, respectively.
Mild MAC observed on transthoracic echocardiography is an important clinical finding with prognostic implications for both valvular function and mortality.
二尖瓣环钙化(MAC)代表一种退行性过程,导致二尖瓣装置中的钙沉积。二尖瓣环钙化与不良的临床结局相关。我们旨在研究轻度 MAC 的长期意义及其与初始超声心动图无二尖瓣功能障碍(MVD)的患者随后发生二尖瓣功能障碍(MVD)和死亡率的关系。
共纳入 1420 例基线时存在轻度 MAC 且无 MVD 且在基线超声心动图后至少 1 年有 1 次或多次随访超声心动图的患者。对于随访期间有 >1 次超声心动图的患者,使用最后一次超声心动图。采用相同标准确定 6496 例无 MAC 的患者。二尖瓣功能障碍定义为中重度或更严重的二尖瓣反流(MR)和/或二尖瓣狭窄(MS)。混合性疾病定义为同时存在中重度 MS 和 MR。主要终点是发生 MVD,次要终点是全因死亡率。
对于轻度 MAC 的患者,年龄为 74 ± 10 岁,528 例(37%)为女性。在中位随访时间为 4.7 年(四分位间距 2.7-6.9 年)期间,215 例轻度 MAC 患者发生 MVD,包括 170 例(79%)MR、37 例(17%)MS 和 8 例(4%)混合性疾病。与无 MAC 的患者相比,在多变量回归模型中,轻度 MAC 的存在与死亡率增加独立相关(危险比=1.43;95%CI 1.24,1.66;P<.001)。轻度 MAC 患者和无 MAC 患者的 Kaplan-Meier 4 年生存率分别为 80%和 90%。
经胸超声心动图观察到的轻度 MAC 是一种重要的临床发现,对瓣膜功能和死亡率均具有预后意义。